Sektor Y-mAbs Therapeutics, Inc.

Aktien

A2N5R0

US9842411095

YMAB

Biotechnologie

Markt geschlossen - Nasdaq 22:00:00 24.01.2025 % 5 Tage % 1. Jan.
6.250 USD -0.48% Intraday Chart für Y-mAbs Therapeutics, Inc. +1.46% -20.18%
Hauptkonkurrenten
Zu einer Liste hinzufügen
% % 5 Tage Veränderung - 1 Monat Veränderung - 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 J. Veränd. 5 J. Veränd. 10 J. Kap. ($)
-0.48%+1.46%-23.31%-56.84%-20.18%-40.70%-41.48%-82.22% - 280 Mio.
-0.03%+4.18%+7.70%-7.97%+9.17%+2.25%+93.57%+91.92%+250.10%113 Mrd.
-2.71%-0.85%-5.41%-27.57%-5.13%-28.78%+12.04%+95.72%+60.82%72.71 Mrd.
+0.94%-2.10%+3.27%+19.85%+4.07%+79.99%+173.26%+369.12%+7’271.90%39.89 Mrd.
-3.26%+5.55%+3.51%+6.93%+3.68%+21.92%-24.51%+237.64% - 28.32 Mrd.
-0.07%+5.71%+22.28%+4.36%+20.23%+34.59%-4.88%+35.78% - 23.67 Mrd.
+2.72%+5.40%+0.40%+5.40%+1.49%-23.78%-49.08%-2.03% - 22.06 Mrd.
-3.61%+24.86%+25.05%+11.76%+33.15%+422.20%+1’042.31%+1’413.95% - 17.52 Mrd.
+0.78%+3.82%+8.94%+28.13%+8.96%+5.47%+95.88%+49.97%+369.18%15.06 Mrd.
+0.82%+8.23%+11.27%+10.60%+13.67%+183.01%+261.83%+290.64%+427.07%14.04 Mrd.
-0.60%-0.43%+1.21%-5.68%+0.70%-21.94%-29.40%-2.05%+263.57%13.45 Mrd.
-0.37%+5.09%+4.34%-20.63%+9.50%+41.39%+400.50% - - 11.17 Mrd.
-2.25%-1.31%-4.46%-11.19%-4.22%-2.97%+69.49%+3.62%+856.55%11.12 Mrd.
+3.87%+1.56%+4.47%+4.59%+3.87%-39.20%-78.68%-47.64% - 9.59 Mrd.
-5.13%-10.55%-4.26%+16.18%-2.76%+46.58%+77.81%+79.69%+1’886.50%9.25 Mrd.
+0.74%-.--%-.--%-.--%-.--%+6.79%+75.83% - - 8.19 Mrd.
+4.50%+9.11%+8.12%-7.49%+8.81%+66.28%+540.74%+213.15%+849.39%7.75 Mrd.
+0.56%+0.05%-7.63%-1.63%-6.88%-2.69%+12.87%-5.60% - 7.67 Mrd.
+2.79%+5.83%+3.99%-9.93%+3.13%+41.95%+153.96% - - 7.21 Mrd.
-3.53%+11.75%+5.17%+55.76%+6.34%+42.56%+422.27%+326.27% - 7.16 Mrd.
Durchschnitt -0.22%+3.70%+3.23%+0.73%+4.38%+41.75%+160.22%+180.47%+1’359.45% 21.97 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung -0.56%+3.63%+4.69%-2.08%+5.71%+31.07%+122.27%+177.94%+1’252.91%
Bio-Therapeutische Medikamente
  1. Börse
  2. Aktien
  3. A2N5R0 Aktie
  4. Sektor Y-mAbs Therapeutics, Inc.